Go-to-Market, Partner & Distribution Strategy

Strengthen how you reach customers, manage partners, structure distribution, and maintain visibility and control across Asian healthcare markets.

Build a Commercial Model That Fits Each Asian Healthcare Market

In many Asian healthcare markets, commercial success depends on local distributors, licence holders, hospital relationships, tender capabilities, regulatory experience, and after-sales support.

However, channel structures vary significantly. A distributor-led model may be essential in one country, while another market may support direct key-account management, multiple specialist partners, or a hybrid model.

Partner-led structures can also create gaps in customer visibility, pricing transparency, account ownership, inventory control, and strategic decision-making. We help healthcare companies understand how customers are reached, how channels perform, and which model best supports their priorities.

How We Strengthen Healthcare Channels Across Asia

• Customer Access Assessment: Map how hospitals, clinicians, pharmacies, laboratories, institutions, and other customers are reached and influenced.
• Route-to-Market Design: Compare direct sales, distributors, agents, licensing, partnerships, digital channels, and hybrid commercial models.
• Partner Identification: Identify distributors, licence holders, commercial partners, healthcare providers, manufacturers, and other participants.
• Partner Evaluation & Selection: Assess candidates based on market access, hospital coverage, regulatory capability, technical expertise, transparency, and resources.
• Distributor Performance Assessment: Review sales performance, customer coverage, pricing, inventory, forecasting, service delivery, reporting, and governance.
• Channel Enhancement: Identify gaps in geographic coverage, customer access, account ownership, technical support, and market visibility.
• Partner Governance & Performance Management: Define roles, decision rights, reporting, indicators, service standards, incentives, and review mechanisms.
• Commercial Model Transition: Support transitions toward direct, hybrid, multi-partner, or more strategically controlled models.

Our Approach to Healthcare Distribution Across Asia

• Map the Asian Commercial Ecosystem: We assess customers, buying pathways, channel participants, partner roles, account relationships, and current routes to market.
• Diagnose Country-Level Performance and Control Gaps: We identify weaknesses in coverage, visibility, pricing, governance, technical capability, service delivery, and alignment.
• Design the Preferred Asian Market Model: We compare commercial options and define the right balance between local execution, investment, speed, access, and control.
• Prepare the Channel Transition Across Asia: We establish partner requirements, governance, implementation phases, responsibilities, performance measures, and transition risks.

Typical Deliverables for Asian Healthcare Channels

• Customer-access and purchasing-pathway map
• Route-to-market assessment
• Direct, distributor, and hybrid-model comparison
• Partner landscape and longlist
• Partner evaluation criteria and scorecard
• Distributor performance assessment
• Channel-gap and coverage analysis
• Partner governance framework
• Commercial-model recommendation
• Transition and implementation roadmap

Supporting Stronger Healthcare Commercial Execution Across Asia

• Reach the Right Customers: Align channel coverage and capabilities with priority accounts and purchasing pathways.
• Improve Asian Market Visibility: Strengthen access to customer, pricing, tender, inventory, and performance information.
• Build Better Local Partnerships: Select and manage partners using clearer expectations, governance, and standards.
• Balance Control and Local Execution: Protect strategic priorities while using strong in-market capabilities.